These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 3771225)

  • 41. Ustur whole body case 0269: demonstrating effectiveness of i.v. CA-DTPA for Pu.
    James AC; Sasser LB; Stuit DB; Glover SE; Carbaugh EH
    Radiat Prot Dosimetry; 2007; 127(1-4):449-55. PubMed ID: 18227077
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Calcium and zinc DTPA administration for internal contamination with plutonium-238 and americium-241.
    Kazzi ZN; Heyl A; Ruprecht J
    Curr Pharm Biotechnol; 2012 Aug; 13(10):1957-63. PubMed ID: 22352730
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Removal of Pu and am from beagles and mice by 3,4,3-LICAM(C) or 3,4,3-LICAM(S).
    Lloyd RD; Bruenger FW; Mays CW; Atherton DR; Jones CW; Taylor GN; Stevens W; Durbin PW; Jeung N; Jones ES
    Radiat Res; 1984 Jul; 99(1):106-28. PubMed ID: 6547537
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Removal of polymeric plutonium by DTPA directed into cells by liposome encapsulation.
    Rosenthal MW; Rahman YE; Moretti ES; Cerny EA
    Radiat Res; 1975 Aug; 63(2):262-74. PubMed ID: 1144691
    [No Abstract]   [Full Text] [Related]  

  • 45. Further studies on the influence of chemical form and dose on absorptions of Np, Pu, Am and Cm from the gastrointestinal tracts of adult and neonatal rodents.
    Sullivan MF; Miller BM; Ruemmler PS; Ryan JL
    Health Phys; 1985 Jan; 48(1):61-73. PubMed ID: 2981787
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Decorporation Approach after Rat Lung Contamination with Plutonium: Evaluation of the Key Parameters Influencing the Efficacy of a Protracted Chelation Treatment.
    Grémy O; Coudert S; Renault D; Miccoli L
    Radiat Res; 2017 Nov; 188(5):552-561. PubMed ID: 28945525
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Combined drug and surgery treatment of plutonium-contaminated wounds: indications obtained using a rodent model.
    Griffiths NM; Coudert S; Wilk JC; Renault D; Angulo JF; Van der Meeren A
    Health Phys; 2014 Jun; 106(6):638-44. PubMed ID: 24776894
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effectiveness of continuously infused DTPA therapy in reducing the radiation dose from inhaled 244Cm2O3 aerosols.
    Guilmette RA; Muggenburg BA
    Health Phys; 1992 Apr; 62(4):311-8. PubMed ID: 1597380
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Research in the complexon series. I. Detoxicant capacity of Ca-DTPA in experimental chronic plutonium poisoning in rats. II. Influence of the repeated intravenous administration of Ca-DTPA on the elimination of trace elements in rats. 3. Preliminary results of the study, in rats, of the modalities of calcium elimination after Ca45-DTPA injection].
    Truhaut R; Boudène C; Lutz M
    Ann Biol Clin (Paris); 1966; 24(3):419-39. PubMed ID: 5932716
    [No Abstract]   [Full Text] [Related]  

  • 50. An analysis of a puncture wound case with medical intervention.
    Bailey BR; Eckerman KF; Townsend LW
    Radiat Prot Dosimetry; 2003; 105(1-4):509-12. PubMed ID: 14527019
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Toward an optimal DTPA therapy for decorporation of actinides: time-dose relationships for plutonium in the dog. I.
    Guilmette RA; Moretti ES; Lindenbaum A
    Radiat Res; 1979 Jun; 78(3):415-28. PubMed ID: 221958
    [No Abstract]   [Full Text] [Related]  

  • 52. Experimental background for prompt treatment with DTPA of 239Pu-contaminated wounds.
    Volf V
    Health Phys; 1974 Sep; 27(3):273-7. PubMed ID: 4436049
    [No Abstract]   [Full Text] [Related]  

  • 53. Efficacy of orally administered amphipathic polyaminocarboxylic acid chelators for the removal of plutonium and americium: comparison with injected Zn-DTPA in the rat.
    Miller SC; Liu G; Bruenger FW; Lloyd RD
    Radiat Prot Dosimetry; 2006; 118(4):412-20. PubMed ID: 16332916
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Synthesis and initial evaluation for in vivo chelation of Pu(IV) of a mixed octadentate spermine-based ligand containing 4-carbamoyl-3-hydroxy-1-methyl-2(1H)-pyridinone and 6-carbamoyl-1-hydroxy-2(1H)-pyridinone.
    Xu J; Durbin PW; Kullgren B; Ebbe SN; Uhlir LC; Raymond KN
    J Med Chem; 2002 Aug; 45(18):3963-71. PubMed ID: 12190318
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Delivery of DTPA through Liposomes as a Good Strategy for Enhancing Plutonium Decorporation Regardless of Treatment Regimen.
    Grémy O; Miccoli L; Lelan F; Bohand S; Cherel M; Mougin-Degraef M
    Radiat Res; 2018 May; 189(5):477-489. PubMed ID: 29528770
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Plutonium-DTPA Model Application with USTUR Case 0269.
    Konzen K; Brey R; Miller S
    Health Phys; 2016 Jan; 110(1):59-65. PubMed ID: 26606066
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Oral Zn-DTPA treatment reduces cadmium absorption and retention in rats.
    Kostial K; Kargacin B; Landeka M
    Toxicol Lett; 1987 Nov; 39(1):71-5. PubMed ID: 3672557
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Lower efficiency of DTPA in reducing cadmium retention in suckling rats.
    Kostial K; Kargacin B; Blanusa M; Landeka M
    Environ Res; 1984 Oct; 35(1):264-9. PubMed ID: 6489293
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Reducing the cancer risk of 239Pu by chelation therapy.
    Jones CW; Mays CW; Taylor GN; Lloyd RD; Packer SM
    Radiat Res; 1986 Sep; 107(3):296-306. PubMed ID: 3749464
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Biokinetic modelling of DTPA decorporation therapy: the CONRAD approach.
    Breustedt B; Blanchardon E; Berard P; Fritsch P; Giussani A; Lopez MA; Luciani A; Nosske D; Piechowski J; Schimmelpfeng J; Sérandour AL
    Radiat Prot Dosimetry; 2009 Feb; 134(1):38-48. PubMed ID: 19351653
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.